1-75807039-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000263187.4(MSH4):c.486A>T(p.Glu162Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000566 in 1,590,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E162K) has been classified as Likely benign.
Frequency
Consequence
ENST00000263187.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH4 | NM_002440.4 | c.486A>T | p.Glu162Asp | missense_variant | 3/20 | ENST00000263187.4 | NP_002431.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH4 | ENST00000263187.4 | c.486A>T | p.Glu162Asp | missense_variant | 3/20 | 1 | NM_002440.4 | ENSP00000263187 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000131 AC: 3AN: 228496Hom.: 0 AF XY: 0.0000161 AC XY: 2AN XY: 124252
GnomAD4 exome AF: 0.00000556 AC: 8AN: 1438024Hom.: 0 Cov.: 31 AF XY: 0.00000699 AC XY: 5AN XY: 715114
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74366
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.486A>T (p.E162D) alteration is located in exon 3 (coding exon 3) of the MSH4 gene. This alteration results from a A to T substitution at nucleotide position 486, causing the glutamic acid (E) at amino acid position 162 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at